NZ337754A - Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge - Google Patents

Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge

Info

Publication number
NZ337754A
NZ337754A NZ337754A NZ33775498A NZ337754A NZ 337754 A NZ337754 A NZ 337754A NZ 337754 A NZ337754 A NZ 337754A NZ 33775498 A NZ33775498 A NZ 33775498A NZ 337754 A NZ337754 A NZ 337754A
Authority
NZ
New Zealand
Prior art keywords
hurstbridge
leptospira
bacterium
serogroup
serovar
Prior art date
Application number
NZ337754A
Other languages
English (en)
Inventor
Roderick J Chappel
Original Assignee
Pig Res & Dev Corp
Agriculture Victoria Serv Pty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pig Res & Dev Corp, Agriculture Victoria Serv Pty filed Critical Pig Res & Dev Corp
Publication of NZ337754A publication Critical patent/NZ337754A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ337754A 1997-03-07 1998-03-06 Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge NZ337754A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO5494A AUPO549497A0 (en) 1997-03-07 1997-03-07 Novel bacterial pathogens
PCT/AU1998/000145 WO1998040099A1 (en) 1997-03-07 1998-03-06 Leptospira pathogens

Publications (1)

Publication Number Publication Date
NZ337754A true NZ337754A (en) 2000-10-27

Family

ID=3799797

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ337754A NZ337754A (en) 1997-03-07 1998-03-06 Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge

Country Status (5)

Country Link
JP (1) JP2002501368A (xx)
AU (1) AUPO549497A0 (xx)
CA (1) CA2283624A1 (xx)
NZ (1) NZ337754A (xx)
WO (1) WO1998040099A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
AU2008343745B2 (en) 2007-10-01 2012-05-10 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
EP2717055A1 (en) 2012-10-04 2014-04-09 Institut Pasteur Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis
GB201410118D0 (en) * 2014-06-06 2014-07-23 Sec Dep For Health The Early diagnosis of leptospire
RU2607006C1 (ru) * 2016-03-03 2017-01-10 Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) Тест-штамм Leptospira interrogans серогруппы Icterohaemorrhagiae серовара copenhageni для детекции антител к L. icterohaemorrhagiae
RU2768008C1 (ru) * 2021-06-21 2022-03-22 Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) Вирулентный штамм бактерий Leptospira interrogans серогруппы Icterohaemorrhagiae серовара copenhageni, используемый для экспериментального изучения лептоспирозной инфекции

Also Published As

Publication number Publication date
JP2002501368A (ja) 2002-01-15
AUPO549497A0 (en) 1997-03-27
CA2283624A1 (en) 1998-09-17
WO1998040099A9 (en) 1999-10-28
WO1998040099A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
NZ337754A (en) Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge
DE69511379D1 (en) Immunogens gegen gonadotropin releasing hormone
MX9302278A (es) Composiciones de vacuna de virus sincicial.
ZA957891B (en) Combination of an oploid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholosm and alcohol dependence
PL318930A1 (en) Mutant enterotoxin effective as a non-toxic adjutant
BR9710740A (pt) FÄrmula de vacina polinucleotidica contra as patologias respiratÄrias e de reprodu-Æo de porcos
ZA934736B (en) Deletion mutants as vaccines for cholera
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
BR0209662A (pt) Método para o tratamento e/ou profilaxia de condições caracterizadas pela função alterada de instestino e/ou dor visceral em seres humanos ou mamìferos não humanos
CA2408537A1 (en) Treating irritable bowel syndrome or disease
CA2270821A1 (en) Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
MY122216A (en) New vaccine and method of use
IL105119A0 (en) Immunoglobins and antigens for the treatment of staphylococcus infections,methods for the identification and preparation thereof and pharmaceutical compositions containing the same
EP1017714A4 (en) PEPTIDE SYNTHESIS PRODUCTS FOR THE DIAGNOSIS AND TREATMENT OF $ i-ASSOCIATED DESMODONTITIS (PORPHYROMONAS GINGIVALIS)
EP0837692A4 (xx)
Pal et al. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge
BR9504573A (pt) Formulaçao farmaceutica adequada para fabricaçao de tabletes dispersiveis por compressao direta tablete de cefaclor dispersivel e processo para fabricaçao de um tablete dispersivel contendo cefaclor
ZA972757B (en) Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.
NO983672L (no) Prevensjonssystem med antibakteriell effekt og/eller antiviruseffekt
IL111101A0 (en) Composition containing lectins for contraception and prophylaxis against diseases transmittable by sexual contact and apparatus for administering lectins
IL123922A (en) Detection, prevention and treatment of papillomatous digital dermatitis in ruminants comprising a therapeutically effective amount of serpens spp
PL348550A1 (en) Ibdv mutant, vaccine containing it for protecting poultry against a disease caused by ibdv and method of protecting poultry against such disease
ITTO920644A0 (it) Dispositivo per depurare e deodorare fumi, in particolare funmi generati da forni per uso odontotecnico, orafo e simili
BR9612245A (pt) Inibidor de óxido nitrico (no) sintase para tratamento ou prevenção de diabetes tipo ii
GB8927980D0 (en) Pharmaceuticals

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: AUSTRALIAN PORK LIMITED, AU

Free format text: OLD OWNER(S): PIG RESEARCH AND DEVELOPMENT CORPORATION; AGRICULTURE VICTORIA SERVICES PTY LTD

Owner name: AGRICULTURE VICTORIA SERVICES PTY LTD, AU

Free format text: OLD OWNER(S): PIG RESEARCH AND DEVELOPMENT CORPORATION; AGRICULTURE VICTORIA SERVICES PTY LTD

RENW Renewal (renewal fees accepted)